(Q47837756)

6 February 2018

title

Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn's disease (English)

1 reference

6 February 2018

1 reference

William Jeffery Sandborn

series ordinal

3

object named as

William J Sandborn

1 reference

6 February 2018

2

Brian G Weinshenker

1 reference

6 February 2018

author name string

Carlton W Thomas

series ordinal

1

1 reference

6 February 2018

publication date

1 January 2004

1 reference

6 February 2018

Inflammatory Bowel Diseases

published in

1 reference

6 February 2018

volume

10

1 reference

6 February 2018

issue

1

1 reference

6 February 2018

page(s)

28-31

1 reference

6 February 2018

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

cites work

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200401000-00004

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200401000-00004

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200401000-00004

Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200401000-00004

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200401000-00004

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200401000-00004

The role of TNFalpha and lymphotoxin in demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200401000-00004

Anti?tumor necrosis factor therapy abrogates autoimmune demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200401000-00004

Tumor necrosis factor identified in multiple sclerosis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200401000-00004

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200401000-00004

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200401000-00004

Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200401000-00004

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200401000-00004

Concurrence of inflammatory bowel disease and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200401000-00004

10.1097/00054725-200401000-00004

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

15058523

1 reference

6 February 2018